Biweekly paclitaxel plus gemcitabine in advanced breast cancer: Phase II trial and predictive value of HER2 extracellular domain

  1. Colomer, R.
  2. Llombart-Cussac, A.
  3. Lluch, A.
  4. Barnadas, A.
  5. Ojeda, B.
  6. Carañana, V.
  7. Fernández, Y.
  8. García-Conde, J.
  9. Alonso, S.
  10. Montero, S.
  11. Hornedo, J.
  12. Guillem, V.
Aldizkaria:
Annals of Oncology

ISSN: 0923-7534

Argitalpen urtea: 2004

Alea: 15

Zenbakia: 2

Orrialdeak: 201-206

Mota: Artikulua

DOI: 10.1093/ANNONC/MDH048 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus